Capsular contracture: why breast implants harden, and what can be done

Ask a Beverly Hills breast surgeon which complication brings the most augmentation patients back for a second operation, and the answer is rarely a ruptured implant. It is capsular contracture: the scar tissue your body forms around any implant tightening and squeezing it. The implant itself is unchanged. The envelope around it is the problem, and understanding that distinction explains almost everything about how contracture is prevented, graded, and treated.

Every implant gets a capsule. Only some capsules misbehave.

When any foreign object is placed in the body, the immune system walls it off with a thin layer of fibrous scar tissue. For a breast implant, that layer is called the capsule, and it is normal, expected, and present in every single patient. In most people it stays thin, soft, and pliable, and it actually holds the implant in position. Capsular contracture is what happens when that capsule thickens, contracts, and tightens around the implant, compressing it into a rounder, firmer shape and, in more advanced cases, distorting the breast and causing pain. The U.S. Food and Drug Administration lists it among the most frequently reported complications of breast implants, for both cosmetic augmentation and reconstruction (FDA: risks and complications of breast implants).

How surgeons grade it: the Baker scale

Contracture is described using a four-point scale that surgeons have used for decades. Grade I means the breast is soft and looks natural, which is to say no clinical contracture at all. Grade II means the breast is slightly firm to the touch but still looks normal. Grade III means the breast is firm and visibly distorted, often riding higher and appearing rounder than intended. Grade IV adds pain to that firmness and distortion. The practical dividing line is between II and III: grades I and II are usually monitored, while grades III and IV are the ones that typically prompt a conversation about surgery.

Timing matters too. Contracture most often appears in the first one to two years after surgery, but it can develop years later, which is one reason implants are best understood as devices with a maintenance horizon rather than a one-time purchase, a point the FDA makes plainly in its patient guidance (FDA: things to consider before getting breast implants).

What causes it, as far as the evidence goes

There is no single cause, but the dominant theory in the surgical literature is bacterial biofilm: a very thin layer of bacteria, often introduced at the time of surgery from the skin or the breast ducts, that colonizes the implant surface without ever causing an obvious infection. That low-grade, chronic stimulus is thought to drive the inflammatory response that thickens the capsule. A second major contributor is hematoma or seroma, blood or fluid collecting around the implant early on, which also inflames the pocket. Reviews of the pathophysiology support both mechanisms and are the reason most modern prevention strategies are essentially infection-control strategies (Current concepts in capsular contracture: pathophysiology, prevention, and management, PubMed).

Several surgical variables shift the odds. Implants placed under the muscle (submuscular) have generally shown lower contracture rates than those placed above it. Radiation therapy to the breast substantially raises the risk, which is why reconstruction patients see contracture more often than cosmetic augmentation patients. Smoking, which impairs healing across the board, is another modifiable factor and one your surgeon will not negotiate on, for reasons that apply to every operation.

What surgeons do to prevent it

Most prevention happens in the operating room, before you ever wake up. Meticulous sterile technique, careful control of bleeding to avoid hematoma, antibiotic or antiseptic irrigation of the pocket, minimal handling of the implant, use of a funnel or sleeve so the implant never touches skin on the way in, and a pocket sized precisely to the device are the core of what is often called the no-touch technique. None of these are exotic, but all of them depend on the surgeon's discipline and the standards of the facility, which is one more reason accreditation and surgeon selection are safety decisions rather than prestige decisions.

Patients have a smaller but real role: following post-operative instructions, taking prescribed antibiotics, avoiding activity that could cause bleeding into the pocket in the early weeks, and attending follow-up so that early firmness is caught while it is still grade II. Some surgeons prescribe a leukotriene receptor antagonist off-label for early contracture, and some recommend specific massage protocols, though the evidence for massage is mixed and it should never be done without your own surgeon's instruction, since the right advice depends on the implant type and pocket.

How it is treated

For mild firmness, observation and sometimes medication are reasonable. For grade III and IV contracture, the definitive treatment is surgical, and the standard operation is a capsulectomy: removing the thickened capsule, often along with the implant, and either replacing the implant, frequently in a fresh pocket or a different plane, or leaving it out entirely. Simply cutting the capsule to release it (capsulotomy) is a lesser procedure with a higher recurrence rate. Recurrence is the honest caveat for all of it: a breast that has contracted once is more likely to contract again, which is why a thorough operation by an experienced revision surgeon matters more here than almost anywhere in aesthetic surgery. This is squarely revision surgery territory, with all of the planning and realistic expectation-setting that implies.

Some patients decide at that point not to replace the implant at all, which is one of the common paths into explant surgery. That is a legitimate outcome, not a failure, and a good surgeon will present it as an option rather than assuming a replacement is automatic.

The takeaway

Capsular contracture is common, well studied, and manageable, but it is also the single best argument for treating breast augmentation as a long-term relationship with a surgeon rather than a one-day transaction. Ask any surgeon you are considering what their contracture rate is, what specific steps they take in the operating room to reduce it, and how they handle it when it happens. A surgeon who answers all three precisely is telling you they track their own outcomes. That, more than any implant brand or marketing claim, is what protects the result you are paying for, and it belongs in the same conversation as everything else worth asking before you book.

Related reading: Breast implant removal: what explant surgery actually involves.